Cart
sales@molnova.com
Mulberroside C
CAS No. 102841-43-0
Mulberroside C( Mulberroside C | Mulberroside-C )
Catalog No. M17760 CAS No. 102841-43-0
Mulberroside C has antioxidant activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 187 | In Stock |
|
| 5MG | 158 | In Stock |
|
| 10MG | 255 | In Stock |
|
| 25MG | 430 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMulberroside C
-
NoteResearch use only, not for human use.
-
Brief DescriptionMulberroside C has antioxidant activity.
-
DescriptionMulberroside C is an inhibitor of HCV replicon cell growth isolated from root barks of Morus atropurpurea.
-
In Vitro——
-
In Vivo——
-
SynonymsMulberroside C | Mulberroside-C
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorAntioxidant
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number102841-43-0
-
Formula Weight458.46
-
Molecular FormulaC24H26O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (136.33 mM)
-
SMILESCC1(C(CC2=C(O1)C=C3C(=C2)C=C(O3)C4=CC(=CC(=C4)OC5C(C(C(CO5)O)O)O)O)O)C
-
Chemical Name(2S,3R,4S,5R)-2-[3-Hydroxy-5-(6-hydroxy-7,7-dimethyl-5,6-dihydrofuro[3,2-g]chromen-2-yl)phenoxy]oxane-3,4,5-triol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MK-0448
MK-0448 is a potent, specific I(Kur) current/Kv1.5 channel inhibitor with IC50 of 8.6 nM, potently inhibits IKur in human atrial myocytes with IC50 of 10.8 nM.
-
Lei-Dab 7
High affinity, selective KCa2.2 (SK2) channel blocker (Kd = 3.8 nM). Exhibits >200-fold selectivity for KCa2.2 over KCa2.1, KCa2.3, KCa3.1, IK, Kv and Kir2.1. Increases theta-burst responses and increases LTP in rat hippocampal slices in vitro. Convulsive in vivo.
-
Dronedarone
A multichannel blocker agent that has antiarrhythmic activity; reduces the late sustained K(+) current, I(K) (or Isus) with EC50 of 0.85 uM in postmyocardial infarcted (PMI) rats.
